Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
Tamburino C, Capranzano P, Gori T, Latib A, Lesiak M, Nef H, Caramanno G, Naber C, Mehilli J, Di Mario C, Sabaté M, Münzel T, Colombo A, Araszkiewicz A, Wiebe J, Geraci S, Jensen C, Mattesini A, Brugaletta S, Capodanno D. Tamburino C, et al. Among authors: nef h. JACC Cardiovasc Interv. 2016 Mar 14;9(5):440-9. doi: 10.1016/j.jcin.2015.10.042. Epub 2016 Jan 6. JACC Cardiovasc Interv. 2016. PMID: 26875648 Free article.
Transapical coronary artery intervention: "first-in-man" experience.
Dörr O, Möllmann H, Achenbach S, Sedding D, Basic D, Liebetrau C, Szardien S, Elsässer A, Roth P, Böning A, Hamm C, Nef HM. Dörr O, et al. Among authors: nef hm. Circ Cardiovasc Interv. 2012 Jun;5(3):446-7. doi: 10.1161/CIRCINTERVENTIONS.112.969170. Circ Cardiovasc Interv. 2012. PMID: 22715451 No abstract available.
"Full bioresorbable jacket": a new era has begun.
Dörr O, Liebetrau C, Hecker F, Wiebe J, Möllmann H, Hamm C, Nef H. Dörr O, et al. Among authors: nef h. Herz. 2015 Apr;40(2):255-6. doi: 10.1007/s00059-013-3912-1. Epub 2013 Aug 2. Herz. 2015. PMID: 23903365 No abstract available.
Bioresorbable scaffolds for the treatment of in-stent restenosis.
Dörr O, Liebetrau C, Wiebe J, Hecker F, Rixe J, Möllmann H, Hamm C, Nef H. Dörr O, et al. Among authors: nef h. Heart Vessels. 2015 Mar;30(2):265-9. doi: 10.1007/s00380-013-0464-5. Epub 2014 Jan 4. Heart Vessels. 2015. PMID: 24390727
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.
Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C. Capodanno D, et al. Among authors: nef h. EuroIntervention. 2015 Feb;10(10):1144-53. doi: 10.4244/EIJY14M07_11. EuroIntervention. 2015. PMID: 25042421 Free article.
396 results